Pacific Biosciences of California(PACB)

搜索文档
Pacific Biosciences of California(PACB) - 2021 Q3 - Earnings Call Transcript
2021-11-03 12:53
Call Start: 16:30 January 1, 0000 5:34 PM ET New Pacific Biosciences of California (NASDAQ:PACB) Q3 2021 Earnings Conference Call November 2, 2021 16:30 ET Company Participants Todd Friedman - Director of Investor Relations Christian Henry - President, Chief Executive Officer & Director Susan Kim - Chief Financial Officer Mark Van Oene - Chief Operating Officer Conference Call Participants Tycho Peterson - JPMorgan Chase Kyle Mikson - Canaccord Genuity Tejas Savant - Morgan Stanley Dan Brennan - Cowen & Com ...
Pacific Biosciences of California (PACB) Presents At 2021 Wells Fargo Virtual Healthcare Conference
2021-10-02 03:42
1 WELLS FARGO HEALTHCARE CONFERENCE SUSAN KIM, CFO © 2021 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ALL RIGHTS RESERVED. PACIFIC BIOSCIENCES SAFE HARBOR STATEMENT All statements in this presentation (and any accompanying oral presentation) that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future ...
Pacific Biosciences of California(PACB) - 2021 Q2 - Quarterly Report
2021-08-06 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (State o ...
Pacific Biosciences of California(PACB) - 2021 Q2 - Earnings Call Transcript
2021-08-04 11:07
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Todd Friedman - Director, IR Christian Henry - President, CEO & Director Susan Kim - CFO Mark Van Oene - COO Conference Call Participants Tycho Peterson - JPMorgan Chase & Co. Tejas Savant - Morgan Stanley Poon Mah - Piper Sandler & Co. Kyle Mikson - Canaccord Genuity Operator Good afternoon, ladies and gentlemen, and welcome to the Pacific Biosciences of California, Inc. Sec ...
Pacific Biosciences of California (PACB) Presents At BofA Securities 2021 Virtual Health Care Conference - Slideshow
2021-05-29 03:05
For Research Use Only. Not for use in diagnostic procedures. © Copyright 2021 by Pacific Biosciences of California, Inc. All rights reserved. BofA Securities 2021 Virtual Health Care Conference Christian Henry President & Chief Executive Officer For Research Use Only. Not for use in diagnostic procedures. © Copyright 2021 by Pacific Biosciences of California, Inc. All rights reserved. | --- | --- | |------------------------------------------------------------------------------------------------------------- ...
Pacific Biosciences of California(PACB) - 2021 Q1 - Quarterly Report
2021-05-06 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (State ...
Pacific Biosciences of California(PACB) - 2021 Q1 - Earnings Call Transcript
2021-04-30 12:22
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2021 Earnings Conference Call April 29, 2021 4:30 PM ET Company Participants Todd Friedman - Director, Investor Relations Christian Henry - President and Chief Executive Officer Susan Kim - Chief Financial Officer Mark Van Oene - Chief Operating Officer Conference Call Participants Kyle Mikson - Cantor Fitzgerald Doug Schenkel - Cowen Tycho Peterson - JP Morgan Tejas Savant - Morgan Stanley Steven Mah - Piper Sandler Operator Ladies and gentlemen, tha ...
Pacific Biosciences of California(PACB) - 2020 Q4 - Annual Report
2021-02-26 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34899 Pacific Biosciences of California, Inc. (Exact name of registrant as specified in its charter) Delaware 16-1590339 (State or ot ...
Pacific Biosciences of California(PACB) - 2020 Q4 - Earnings Call Transcript
2021-02-11 09:14
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4, 2020 Earnings Conference Call February 10, 2021 4:30 PM ET Company Participants Trevin Rard - Investor Relations Christian Henry - President & Chief Executive Office Susan Kim - Chief Financial Officer Mark Van Oene - Chief Operating Officer Conference Call Participants Doug Schenkel - Cowen Tejas Savant - Morgan Stanley Tycho Peterson - JPMorgan Rachel Vatnsdal - Piper Sandler Kyle Mikson - Cantor Fitzgerald Operator Thank you for standing by, and w ...
Pacific Biosciences of California(PACB) - 2020 Q3 - Earnings Call Transcript
2020-11-03 12:14
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2020 Earnings Conference Call November 2, 2020 4:30 PM ET Company Participants Trevin Rard - Investor Relations Christian Henry - Chief Executive Office Susan Kim - Chief Financial Officer Ben Gong - Vice President of Finance and Treasurer Conference Call Participants Doug Schenkel - Cowen Tejas Savant - Morgan Stanley Tycho Peterson - JPMorgan Kyle Mikson - Cantor Fitzgerald Steven Mah - Piper Sandler Operator Good afternoon, ladies and gentlemen, an ...